SCHEMBL19930783

SCHEMBL19930783

CCCc1cnc(NSCC)nc1-c1cn(C)c(=O)c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.43
USP2 O75604 6/20 0.43
CYP1A2 P05177 6/20 0.43
CASP1 P29466 6/20 0.43
CASP7 P55210 6/20 0.43
KMT2A Q03164 6/20 0.43
CYP3A4 P08684 5/20 0.43
LMNA P02545 4/20 0.43
CYP2C9 P11712 4/20 0.43
ALDH1A1 P00352 4/20 0.43
CYP2D6 P10635 3/20 0.43
HIF1A Q16665 2/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
BRD4 O60885 12/20 0.41
MAPK1 P28482 2/20 0.40
CLK4 Q9HAZ1 2/20 0.40
TSHR P16473 1/20 0.38
BRCA1 P38398 1/20 0.38
HBB P68871 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25043383 0.94 MEN1 (0.40) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL19930864 0.93 BRD4 (0.43) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL16650709 0.83 BRD4 (0.49) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL29848858 0.83 BRD4 (0.49) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL19930778 0.80 CDK5 (0.49) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL19931265 0.79 BRD4 (0.40) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL29848848 0.78 BRD4 (0.47) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL16651985 0.78 BRD4 (0.47) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL29848819 0.78 BRD4 (0.43) MEN1USP2CYP1A2CASP1CASP7
SCHEMBL29848814 0.78 BRD4 (0.43) MEN1USP2CYP1A2CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4134364-A2 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2023-02-15 EP disclosed
EP-3640241-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2020-04-22 EP disclosed
EP-3290407-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc (US) 2018-03-07 EP disclosed